Clinical Trial Update: Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is an update on a Phase 1-2 trial of onapristone in patients with advanced castration-resistant prostate cancer, with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Onapristone (onapristone)

Snippet

Sponsor: Arno Therapeutics | Conditions: Prostate Cancer, Metastatic Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN